ISCHEMIA
Treating ischemia with either medical or invasive treatment (stent or bypass).
Principal investigator: Charles Cannan, M.D.
Subinvestigators: Robert Hodson, M.D., and Steven Reinhart, M.D.
Sponsor: NHLBI
Contact: Jan Coan, CCRC, study coordinator, 503-962-1026, or Michelle Dixon, CCRC, 503-962-1026.
TRILOGY ACS
Phase III study to compare Prasugrel and Clopidogrel in acute coronary syndrome subjects with unstable angina/non-ST-elevated myocardial infarction who are medically managed.
Sponsor: Eli Lilly
Principal investigator: Xiaoyan Huang, M.D.
Contact: Jan Coan, CCRC, study coordinator, 503-962-1026
PEGASUS-TIMI-54
Assess the Prevention of Thrombotic Events with Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients with History of Myocardial Infarction
Sponsor: The Brigham and Women’s Hospital Inc.
Principal Investigator: Robert Hodson, M.D.
Contact: Jan Coan, CCRC, study coordinator, 503-962-1026
SAVOR-TIMI-53
A multi-center, randomized, double-blind, placebo-controlled phase IV trial to evaluate the effect of Saxagliptin on the incidence of cardiovascular death, myocardial infarction or ischemic stroke in patients with Type 2 diabetes
Sponsor: AstraZeneca
Principal investigator: Robert Hodson, M.D.
Contact: Jan Coan, CCRC, study coordinator, 503-962-1026
SOLID-TIMI-52
The Stabilization Of pLaques using Darapladib Thrombolysis In Myocardial Infarction Trial
A clinical outcomes study of Darapladib versus placebo in subjects following acute coronary syndrome to compare the incidence of major adverse cardiovascular events (MACE).
Sponsor: GlaxoSmithKline
Principal investigator: Robert Hodson, M.D.
Contact: Jan Coan, CCRC, study coordinator, 503-962-1026